This content is machine translated Chronic Hepatitis B: Is a Cure in Sight? Phase III Trial of Temporary Treatment with Bepirovirsen Was Successful Hepatitis B is the most common form of viral hepatitis worldwide—dreaded complications include liver cirrhosis and hepatocellular carcinoma (HCC). Treatment with Bepirovirsen, an antisense oligonucleotide that targets mRNAs of the...…
